4IG
PFE icon

440 Investment Group’s Pfizer PFE Stock Holding History

440 Investment Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.12M Buy
32,628
+633
+2% +$21.6K 0.8% 32
2017
Q3 		$1.08M Sell
31,995
-4,005
-11% -$129K 0.83% 34
2017
Q2 		$1.15M Buy
36,000
+20,462
+132% +$645K 0.91% 28
2017
Q1 		$504K Buy
+15,538
New +$490K 0.45% 53

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

440 Investment Group's PFE Position: Q4 2017 in Review

440 Investment Group increased its Pfizer (PFE) stake by 2% in Q4 2017, buying an estimated $21.6K and bringing the position to 32,628 shares worth $1.12M. The position accounts for 0.8% of the portfolio, ranked #32.

440 Investment Group first reported a position in PFE in Q1 2017 and has held it in 4 quarters since. The position peaked at $1.15M in Q2 2017. 2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • 440 Investment Group held 32,628 shares of Pfizer worth $1.12M as of Q4 2017.
  • 440 Investment Group bought 633 Pfizer shares in Q4 2017, an estimated $21.6K.
  • Pfizer made up 0.8% of 440 Investment Group's portfolio in Q4 2017, its #32 holding.
  • 440 Investment Group first reported a position in Pfizer in Q1 2017 and has held it in 4 quarters since.
  • 440 Investment Group's Pfizer position peaked at $1.15M in Q2 2017.
  • 2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on 440 Investment Group's 13F filing for Q4 2017, filed 16 Jan 2018.